These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Australia reviews medical research funding. Pockley P Nature; 1998 Mar; 392(6672):116. PubMed ID: 9515948 [No Abstract] [Full Text] [Related]
6. Is there a federal philosophy about academic medicine. Fredrickson DS Bull N Y Acad Med; 1981; 57(6):454-69. PubMed ID: 6941839 [No Abstract] [Full Text] [Related]
7. The influence of governmental decision-making on academic medicine: view from the government of Québec. Iglesias JR Clin Invest Med; 1992 Jun; 15(3):293-4. PubMed ID: 1638812 [No Abstract] [Full Text] [Related]
8. Health care and research in Canada, 1978. Part II. Genest J Can Med Assoc J; 1978 Sep; 119(6):614, 619, 622-5. PubMed ID: 101288 [No Abstract] [Full Text] [Related]
9. The uncertain future of Canadian academic medicine. Hollenberg CH Clin Invest Med; 1990 Aug; 13(4):227-31. PubMed ID: 2208840 [TBL] [Abstract][Full Text] [Related]
10. Canada. Research budgets are tight pending science policy review. Kondro W Science; 2006 May; 312(5775):831. PubMed ID: 16690828 [No Abstract] [Full Text] [Related]
11. The influence of governmental decision-making on academic medicine: the Quebec experience. Macklem PT Clin Invest Med; 1990 Aug; 13(4):219-22. PubMed ID: 2208838 [TBL] [Abstract][Full Text] [Related]
12. Science lobby 'ecstatic' after triumph in NIH budget battle. Wadman M Nature; 1999 Nov; 402(6760):334. PubMed ID: 10586855 [No Abstract] [Full Text] [Related]
13. Surprise US election results may boost biotech. Fox JL Nat Biotechnol; 2002 Dec; 20(12):1176. PubMed ID: 12454655 [No Abstract] [Full Text] [Related]
14. The role of physicians in political advocacy. Results of a Canadian Society of Nephrology survey. Phillips N; Barrett B; Mendelssohn DC Nephrol News Issues; 2008 Dec; 22(13):32-3, 36-7. PubMed ID: 19149315 [No Abstract] [Full Text] [Related]
15. Lobbyists elated as the NIH wins $2bn budget increase. Macilwain C Nature; 1998 Oct; 395(6704):734. PubMed ID: 9796802 [No Abstract] [Full Text] [Related]
17. More rare disease money. Bonetta L Nat Med; 2002 Nov; 8(11):1190-1. PubMed ID: 12411930 [No Abstract] [Full Text] [Related]
18. [EVO-funds are a shot for Finnish research]. Vihko R Duodecim; 1995; 111(19):1821-3, 1825. PubMed ID: 9340281 [No Abstract] [Full Text] [Related]
19. Symposium on the academic physician: an endangered species. Recommendations for remedies. Their SO Bull N Y Acad Med; 1981; 57(6):480-7. PubMed ID: 6941842 [No Abstract] [Full Text] [Related]
20. Medical research policy for Canada. Potential dialogue between MD and MP. Seeman P Can Med Assoc J; 1974 Oct; 111(7):707-9, 730. PubMed ID: 4414625 [No Abstract] [Full Text] [Related] [Next] [New Search]